Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-Nī-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate

EU orphan designation number: EU/3/10/747   
Active ingredient: N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N´-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate
Indication: Treatment of renal cell carcinoma
Sponsor: AVEO Pharma Ltd.
59-60 Thames St., Windsor, SL41 TX, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2010 Centralised Orphan - Designation EMEA/OD/148/09 (2010)3840 of 09/06/2010
07/03/2012 Centralised Orphan - Transfer of orphan designation EMEA/OD/148/09/T/01 (2012)1538 of 05/03/2012
04/02/2013 Other procedure
26/09/2014 Centralised Orphan - Transfer of orphan designation EMA/OD/148/09/T/02 (2014)7016 of 24/09/2014